2025 Annual Report of Independent Director (Lin Hong)
I, Lin Hong, as the independent director of Shanghai Kaixin Separation Technology Co., Ltd. (hereinafter referred to as "the Company"), have diligently fulfilled my responsibilities in accordance with the Company Law of the People's Republic of China, the Securities Law of the People's Republic of China, the Management Measures for Independent Directors of Listed Companies, the Listing Rules for the Growth Enterprise Market of the Shenzhen Stock Exchange, the Self-Regulatory Guidelines for Listed Companies No. 2 - Standardized Operations of Growth Enterprise Market Listed Companies, as well as the Company’s Articles of Association and the Independent Director Work System. In 2025, I have actively performed my role as an independent director, safeguarding the overall interests of the Company and the legitimate rights and interests of all shareholders, especially minority shareholders. The following is my report on the performance of independent director duties for the year 2025:
I. Basic Information of the Independent Director
Lin Hong, male, born in 1961, holds a master's degree, and is a Chinese national without permanent residency abroad. From September 2005 to March 2007, I served as the Chairman of Jing Shan Kailong Explosive Materials Co., Ltd.; from September 2005 to March 2007, I was also the Chairman and Manager of Jing Shan Kailong Asset Management Co., Ltd.; from April 2007 to April 2018, I served as the Deputy General Manager and Secretary of the Board of Hubei Kailong Chemical Group Co., Ltd.; from May 2018 to May 2021, I was the General Manager and Secretary of the Board of Hubei Kailong Chemical Group Co., Ltd.; from December 2021 to July 2024, I served as the Special Assistant to the Chairman of Wuhan Geological Resources and Environment Research Institute Co., Ltd. and the Chairman of Wuhan Zhongji Hydrogen Energy Industry Innovation Center Co., Ltd. Since October 2021, I have been serving as the independent director of this Company. During the reporting period, my position complies with the independence requirements stipulated in Article 6 of the Management Measures for Independent Directors of Listed Companies, and there are no circumstances affecting my independence.
II. Annual Performance of Duties
(A) Attendance at Board and Shareholder Meetings
In 2025, the Company held 7 board meetings and 4 shareholder meetings. The operations of the board and shareholder meetings complied with legal procedures. With a prudent attitude, I voted in favor of all proposals submitted at each board meeting after review, and did not express any objections or abstentions. My attendance at board and shareholder meetings during the reporting period is as follows: